These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 22900541)

  • 1. AA-Amyloid is cleared by endogenous immunological mechanisms.
    Nyström SN; Westermark GT
    Amyloid; 2012 Sep; 19(3):138-45. PubMed ID: 22900541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis.
    Mihara M; Shiina M; Nishimoto N; Yoshizaki K; Kishimoto T; Akamatsu K
    J Rheumatol; 2004 Jun; 31(6):1132-8. PubMed ID: 15170926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FK506 inhibits murine AA amyloidosis: possible involvement of T cells in amyloidogenesis.
    Ueda M; Ando Y; Nakamura M; Yamashita T; Himeno S; Kim J; Sun X; Saito S; Tateishi T; Bergström J; Uchino M
    J Rheumatol; 2006 Nov; 33(11):2260-70. PubMed ID: 16981291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor.
    Sørby R; Espenes A; Landsverk T; Westermark G
    Amyloid; 2008 Mar; 15(1):20-8. PubMed ID: 18266118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical AA amyloid deposits in bovine AA amyloidosis.
    Murakami T; Inoshima Y; Kobayashi Y; Matsui T; Inokuma H; Ishiguro N
    Amyloid; 2012 Mar; 19(1):15-20. PubMed ID: 22149364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient amyloid A clearance in the absence of immunoglobulins and complement factors.
    Sponarova J; Nuvolone M; Whicher C; Frei N; Kana V; Schwarz P; Westermark GT; Aguzzi A
    Am J Pathol; 2013 Apr; 182(4):1297-307. PubMed ID: 23454183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of amyloid in murine and human secondary amyloidosis by the immunoperoxidase technique.
    Livni N; Laufer A; Levo Y
    J Pathol; 1980 Dec; 132(4):343-8. PubMed ID: 7003080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin: its potential significance in murine AA amyloidogenesis.
    Chronopoulos S; Lembo P; Alizadeh-Khiavi K; Ali-Khan Z
    J Pathol; 1992 Jun; 167(2):249-59. PubMed ID: 1321903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis.
    Westermark GT; Westermark P
    FEBS Lett; 2009 Aug; 583(16):2685-90. PubMed ID: 19393650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid A protein amyloidosis induced in apolipoprotein-E-deficient mice.
    Hoshii Y; Kawano H; Cui D; Takeda T; Gondo T; Takahashi M; Kogishi K; Higuchi K; Ishihara T
    Am J Pathol; 1997 Oct; 151(4):911-7. PubMed ID: 9327723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense oligonucleotide suppression of serum amyloid A reduces amyloid deposition in mice with AA amyloidosis.
    Kluve-Beckerman B; Hardwick J; Du L; Benson MD; Monia BP; Watt A; Crooke RM; Mullick A
    Amyloid; 2011 Sep; 18(3):136-46. PubMed ID: 21830877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceleration of murine AA amyloid deposition by bovine amyloid fibrils and tissue homogenates.
    Cui D; Kawano H; Hoshii Y; Liu Y; Ishihara T
    Amyloid; 2008 Jun; 15(2):77-83. PubMed ID: 18484333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid membranes accelerate amyloid formation in the mouse model of AA amyloidosis.
    Vahdat Shariat Panahi A; Hultman P; Öllinger K; Westermark GT; Lundmark K
    Amyloid; 2019 Mar; 26(1):34-44. PubMed ID: 30929476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deposition, Clearance, and Reinduction of Amyloid A Amyloid in Interleukin 1 Receptor Antagonist Knockout Mice.
    Watanabe K; Uchida K; Chambers JK; Ushio N; Nakayama H
    Vet Pathol; 2017 Jan; 54(1):99-110. PubMed ID: 27565681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmission of circulating cell-free AA amyloid oligomers in exosomes vectors via a prion-like mechanism.
    Tasaki M; Ueda M; Ochiai S; Tanabe Y; Murata S; Misumi Y; Su Y; Sun X; Shinriki S; Jono H; Shono M; Obayashi K; Ando Y
    Biochem Biophys Res Commun; 2010 Oct; 400(4):559-62. PubMed ID: 20807507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E1 inhibition of experimental amyloidosis in CBA/J mice.
    Brandwein SR; Sipe JD; Skinner M; Cohen AS
    J Rheumatol; 1985 Jun; 12(3):418-26. PubMed ID: 4045840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term kinetics of AA amyloidosis and effects of inflammatory restimulation after disappearance of amyloid depositions in mice.
    Muhammad N; Murakami T; Inoshima Y; Ishiguro N
    Clin Exp Immunol; 2015 Jul; 181(1):133-41. PubMed ID: 25736960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of perlecan gene expression precedes amyloid formation during experimental murine AA amyloidogenesis.
    Ailles L; Kisilevsky R; Young ID
    Lab Invest; 1993 Oct; 69(4):443-8. PubMed ID: 8231112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice.
    de Villiers WJ; Varilek GW; de Beer FC; Guo JT; Kindy MS
    Cytokine; 2000 Sep; 12(9):1337-47. PubMed ID: 10975993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of ubiquitin to experimentally induced murine AA amyloid.
    Chronopoulos S; Alizadeh-Khiavi K; Normand J; Ali-Khan Z
    J Pathol; 1991 Mar; 163(3):199-203. PubMed ID: 1707449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.